Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.38 |
| ▸ | SNCA | P37840 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.38 |
| ▸ | CA2 | P00918 | 1/20 | 0.38 |
| ▸ | FLT1 | P17948 | 1/20 | 0.38 |
| ▸ | FLT4 | P35916 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | SERPINE1 | P05121 | 1/20 | 0.36 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.35 |
| ▸ | NT5E | P21589 | 1/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10596213 | 0.91 | ALDH1A1 (0.41) | SNCAALDH1A1HSD17B10CA2MAPT | |
| SCHEMBL4620923 | 0.90 | S1PR3 (0.43) | FFAR4S1PR3SNCAALDH1A1HSD17B10 | |
| SCHEMBL10652394 | 0.88 | S1PR3 (0.45) | S1PR3ALDH1A1CA2MAPTATM | |
| Ammonia Solution, Strong SCHEMBL28286823 | 0.88 | S1PR3 (0.42) | FFAR4S1PR3SNCAALDH1A1HSD17B10 | |
| SCHEMBL10598218 | 0.87 | SNCA (0.39) | S1PR3SNCAALDH1A1HSD17B10CA2 | |
| SCHEMBL1607817 | 0.87 | ALDH1A1 (0.41) | S1PR3SNCAALDH1A1HSD17B10CA2 | |
| SCHEMBL8764128 | 0.87 | S1PR3 (0.47) | S1PR3ALDH1A1CA2MAPTATM | |
| SCHEMBL7071455 | 0.87 | S1PR3 (0.47) | S1PR3ALDH1A1CA2MAPTATM | |
| SCHEMBL451722 | 0.87 | S1PR3 (0.47) | S1PR3ALDH1A1CA2MAPTATM | |
| SCHEMBL8578052 | 0.87 | S1PR3 (0.47) | S1PR3ALDH1A1CA2MAPTATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2162481-A1 | PROCESS FOR PREPARING COMPOSITES USING EPOXY RESIN COMPOSITIONS | Dow Global Technologies Inc. (US) | 2010-03-17 | — | — | EP | claimed |
| WO-2008153542-A1 | PROCESS FOR PREPARING COMPOSITES USING EPOXY RESIN COMPOSITIONS | DOW GLOBAL TECHNOLOGIES, INC. (US) | 2008-12-18 | — | — | WO | claimed |
| US-20080308972-A1 | Process for Preparing Composites Using Epoxy Resin Formulations | DOW GLOBAL TECHNOLOGIES LLC | 2008-12-18 | — | — | US | claimed |
| EP-1824827-B1 | METHOD FOR PRODUCING ONIUM SALTS COMPRISING ALKYL ANIONS OR ARYL SULFONATE ANIONS OR ALKYL ANIONS OR ARYL CARBOXYLATE ANIONS HAVING A LOW HALIDE CONTENT | MERCK PATENT GMBH (DE) | 2008-09-17 | — | — | EP | claimed |
| WO-2023220046-A1 | TYK2 INHIBITORS | BIOGEN MA INC. (US) | 2023-11-16 | — | — | WO | disclosed |
| EP-3660014-B1 | ALKALOID DERIVATIVE HAVING ANGIOGENESIS INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SEOUL NAT UNIV R&DB FOUNDATION (KR) | 2023-08-30 | — | — | EP | disclosed |
| US-11168081-B2 | Alkaloid derivative having angiogenesis inhibitory effect, and pharmaceutical composition containing same | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2021-11-09 | — | — | US | disclosed |
| US-20210087185-A1 | ALKALOID DERIVATIVE HAVING ANGIOGENESIS INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) | 2021-03-25 | — | — | US | disclosed |
| EP-3660014-A1 | ALKALOID DERIVATIVE HAVING ANGIOGENESIS INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | Seoul National University R&DB Foundation (KR) | 2020-06-03 | — | — | EP | disclosed |
| CN-108794286-A | The method for producing fluorinated compound using the alcoholic solvent with carbonyl | 未来化学株式会社 | 2018-11-13 | — | — | CN | disclosed |
| CN-105085482-B | Substituted diethylenediamine compound and its application method and purposes | 广东东阳光药业有限公司 | 2018-08-10 | — | — | CN | disclosed |
| CN-107406607-A | Fiber reinforced composite material two-component-type composition epoxy resin and fiber reinforced composite material | 东丽株式会社 | 2017-11-28 | — | — | CN | disclosed |
| WO-1992011400-A1 | AZEOTROPE-LIKE COMPOSITIONS OF DICHLOROPENTAFLUOROPROPANE, AN ALKANOL HAVING 1-3 CARBON ATOMS AND 2-METHYL-2-PROPANOL | ALLIED-SIGNAL INC. (US) | 1992-07-09 | — | — | WO | disclosed |
| WO-1991005035-A1 | AZEOTROPE-LIKE COMPOSITIONS OF DICHLOROPENTAFLUOROPROPANE AND AN ALKANOL HAVING 1-4 CARBON ATOMS | ALLIED-SIGNAL INC. (US) | 1991-04-18 | — | — | WO | disclosed |
| EP-0190588-A1 | Quinazolino-1,4-benzodiazepin-6,9-diones, processes for their preparation and pharmaceutical compositions containing them | MERCK & CO. INC. (US) | 1986-08-13 | — | — | EP | disclosed |
| US-4554272-A | CHOLECYSTOKININ INHIBITORS | MERCK & CO., INC. (US) | 1985-11-19 | — | — | US | disclosed |
| US-4161524-A | INSECTICIDES, MITICIDES, NEMATOCIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1979-07-17 | — | — | US | disclosed |
| US-4134979-A | INSECTICIDES, MITICIDES, NEMATOCIDES | BAYER AKTIENGESELLSCHAFT (DE) | 1979-01-16 | — | — | US | disclosed |
| US-4093575-A | WITH A HYDROXYALKYL ACRYLATE OR VINYL ALCOHOL, BLENDED WITH CELLULOSE ACETATE BUTYRATE AND A UREA-, MELAMINE-, OR PHENOL-FORMALDEHYDE OR BLOCKED ISOCYANATE CROSSLINKER | UNION CARBIDE CORPORATION (US) | 1978-06-06 | — | — | US | disclosed |
| US-3932377-A | Hydrosoluble monoazoic cationic dyes and process for preparing same | MONTECATINI EDISON S.P.A. (IT) | 1976-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11168081-B2 | Alkaloid derivative having angiogenesis inhibitory effect, and pharmaceutical composition containing same | GPR119, GIPR, UACA | FFAR4 516/4885S1PR3 1093/4885SNCA 1316/4885 |
| US-20210087185-A1 | ALKALOID DERIVATIVE HAVING ANGIOGENESIS INHIBITORY EFFECT, AND PHARMACEUTICAL COMPOSITION CONTAINING SAME | GIPR, VEGFA, UACA | FFAR4 630/4885S1PR3 1055/4885SNCA 1513/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.